7 Jun 2021 The Food and Drug Administration on Monday approved the first new treatment for Alzheimer’s disease in nearly two decades, a landmark decision that has been eagerly awaited by millions of Americans diagnosed with the condition but that will be hotly contested by some in the scientific community who doubt the drug’s effectiveness. Read More By Adam Feuerstein and Damian Garde
7 Jul NPR: Alzheimer’s drug gets full FDA approval. Medicare coverage will likely follow July 6, 20234:48 PM ET Heard on Morning Edition Jon... Read More
31 Mar NPR: CDC recommends 2nd COVID boosters for some older and immunocompromised people Updated March 29, 20224:21 PM ET Heard on Morning... Read More
28 Dec Texas Assisted Living Facilities Receive COVID-19 Vaccine CVS to begin vaccinating Texas senior living facilities Monday... Read More